This first column of "Drug Discovery" chronicles the development of the drug discovery process and explains how separation technologies fit in the world of drug discovery.
LCGC 18(1), 42–44 (2000).Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.